FDA
-
-
-
-
-
-
-
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet
-
-
-
-
-
-
-
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities
-
-
-
-
-
-
-
ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 Meeting
-
-
-
-
-
-
-
ANI Pharmaceuticals Announces Presentation of New Preclinical Data
-
-
-
-
-
-
-
ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®
-
-
-
-
-
-
-
ANI Pharma (ANIP) Reports Prelim Q4, 2025 Outlook
-
-
-
-
-
-
-
ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024
-
322,969 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

